SCHEMBL4353102

SCHEMBL4353102

NC(=O)N(c1cccc(O)c1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 5/20 0.41
TSHR P16473 4/20 0.41
PARP1 P09874 1/20 0.40
CYP3A4 P08684 3/20 0.38
MAPK14 Q16539 2/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 2/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
HTT P42858 1/20 0.34
CASP7 P55210 1/20 0.34
CA12 O43570 3/20 0.34
CA2 P00918 3/20 0.34
CA9 Q16790 3/20 0.34
CA1 P00915 2/20 0.34
CA14 Q9ULX7 2/20 0.34
CA7 P43166 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983114 0.87 TSHR (0.42) HSD17B10ALDH1A1TSHRCYP3A4MAPK14
SCHEMBL11804404 0.87 ALDH1A1 (0.52) HSD17B10ALDH1A1TSHRPARP1CYP3A4
SCHEMBL29504742 0.80 NPC1 (0.42) ALDH1A1TSHRCYP3A4MEN1KMT2A
SCHEMBL337227 0.80 NPC1 (0.42) ALDH1A1TSHRCYP3A4MEN1KMT2A
SCHEMBL6037581 0.79 ALDH1A1 (0.46) HSD17B10ALDH1A1TSHRPARP1CYP3A4
SCHEMBL27742343 0.75 TSHR (0.41) HSD17B10ALDH1A1TSHRPARP1CYP3A4
SCHEMBL27950444 0.74 HTR3E (0.53) ALDH1A1TSHRPARP1MEN1KMT2A
SCHEMBL11411868 0.74 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ALMNAHTT
SCHEMBL1879907 0.73 ALDH1A1 (0.42) HSD17B10ALDH1A1TSHRCYP3A4MEN1
SCHEMBL4588620 0.72 HTR3E (0.47) ALDH1A1TSHRPARP1CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009054878-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEOPLASIA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) 2009-04-30 WO disclosed